{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:02:44Z","timestamp":1768514564915,"version":"3.49.0"},"posted":{"date-parts":[[2024,9,24]]},"group-title":"Pathology","reference-count":60,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>\n                    The pathological effects of amyloid \u03b2 oligomers (A\u03b2o) may be mediated through the metabotropic glutamate receptor subtype 5 (mGluR5), leading to synaptic loss in Alzheimer\u2019s disease (AD). Positron emission tomography (PET) studies of mGluR5 using [\n                    <jats:sup>18<\/jats:sup>\n                    F]FPEB indicate a reduction of receptor binding that is focused in the medial temporal lobe in AD. Synaptic loss due to AD measured through synaptic vesicle glycoprotein 2A (SV2A) quantification with [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J PET is also focused in the medial temporal lobe, but with clear widespread reductions is commonly AD-affected neocortical regions. In this study, we used [\n                    <jats:sup>18<\/jats:sup>\n                    F]FPEB and [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J PET to investigate the relationship between mGluR5 and synaptic density in early AD.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    Fifteen amyloid positive participants with early AD and 12 amyloid negative, cognitively normal (CN) participants underwent PET scans with both [\n                    <jats:sup>18<\/jats:sup>\n                    F]FPEB to measure mGluR5 and [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J to measure synaptic density. Parametric\n                    <jats:italic>DVR<\/jats:italic>\n                    images using equilibrium methods were generated from dynamic. For [\n                    <jats:sup>18<\/jats:sup>\n                    F]FPEB PET,\n                    <jats:italic>DVR<\/jats:italic>\n                    was calculated using equilibrium methods and a cerebellum reference region. For [\n                    <jats:sup>11<\/jats:sup>\n                    C]UCB-J PET,\n                    <jats:italic>DVR<\/jats:italic>\n                    was calculated with a simplified reference tissue model \u2013 2 and a whole cerebellum reference region.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Result<\/jats:title>\n                  <jats:p>\n                    A strong positive correlation between mGluR5 and synaptic density was present in the hippocampus for participants with AD (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.81,\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001) and in the CN group (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.74,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.005). In the entorhinal cortex, there was a strong positive correlation between mGluR5 and synaptic in the AD group (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.85,\n                    <jats:italic>p<\/jats:italic>\n                    &lt;0.001), but a weaker non-significant correlation in the CN group (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.36,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.245). Exploratory analyses within and between other brain regions suggested significant positive correlations between mGluR5 in the medial temporal lobe and synaptic density in a broader set of commonly AD-affected regions.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Medial temporal loss of mGluR5 in AD is associated with synaptic loss in both medial temporal regions and more broadly in association cortical regions, indicating that mGluR5 mediated A\u03b2o toxicity may lead to early synaptic loss more broadly in AD-affected networks. In CN individuals, an isolated strong association between lower mGluR5 and lower synaptic density may indicate non-AD related synaptic loss.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.21.614277","type":"posted-content","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T09:09:16Z","timestamp":1727168956000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer\u2019s disease: a multi-tracer PET study"],"prefix":"10.64898","author":[{"given":"Elaheh","family":"Salardini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan S.","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Em","family":"Tchorz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeel B.","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"van Dyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P.","family":"Mecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024092614550500000_2024.09.21.614277v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(90)90059-9"},{"key":"2024092614550500000_2024.09.21.614277v1.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074069"},{"key":"2024092614550500000_2024.09.21.614277v1.3","doi-asserted-by":"crossref","unstructured":"DeKosky ST , Sche1 SW , Styren SD . Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration. 1996;5(4):417\u201321.","DOI":"10.1006\/neur.1996.0056"},{"key":"2024092614550500000_2024.09.21.614277v1.4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.3.355"},{"key":"2024092614550500000_2024.09.21.614277v1.5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270502"},{"key":"2024092614550500000_2024.09.21.614277v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300410"},{"issue":"7","key":"2024092614550500000_2024.09.21.614277v1.7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"In vivo measurement of widespread synaptic loss in Alzheimer\u2019s disease with SV2A PET","volume":"16","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2024092614550500000_2024.09.21.614277v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90121-X"},{"key":"2024092614550500000_2024.09.21.614277v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.09.012"},{"issue":"3","key":"2024092614550500000_2024.09.21.614277v1.10","first-page":"1073","article-title":"Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer\u2019s disease","volume":"43","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"2024092614550500000_2024.09.21.614277v1.11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6667"},{"key":"2024092614550500000_2024.09.21.614277v1.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.168179"},{"issue":"10","key":"2024092614550500000_2024.09.21.614277v1.13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging","volume":"75","year":"2018","journal-title":"JAMA Neurol"},{"key":"2024092614550500000_2024.09.21.614277v1.14","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994"},{"key":"2024092614550500000_2024.09.21.614277v1.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.6.2150"},{"issue":"1","key":"2024092614550500000_2024.09.21.614277v1.16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","article-title":"Association of A\u03b2 deposition and regional synaptic density in early Alzheimer\u2019s disease: a PET imaging study with [(11)C]UCB-J","volume":"13","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"2024092614550500000_2024.09.21.614277v1.17","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X231153730"},{"issue":"7","key":"2024092614550500000_2024.09.21.614277v1.18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0271678X241230733","article-title":"The associations between synaptic density and \u201cA\/T\/N\u201d biomarkers in Alzheimer\u2019s disease: An (18)F-SynVesT-1 PET\/MR study","volume":"44","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"2024092614550500000_2024.09.21.614277v1.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04461-x"},{"issue":"1","key":"2024092614550500000_2024.09.21.614277v1.20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13195-021-00772-0","article-title":"In vivo tau pathology is associated with synaptic loss and altered synaptic function","volume":"13","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"2024092614550500000_2024.09.21.614277v1.21","first-page":"e545","article-title":"In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment","volume":"95","year":"2020","journal-title":"Neurology"},{"issue":"10","key":"2024092614550500000_2024.09.21.614277v1.22","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1038\/s41380-022-01672-x","article-title":"Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern","volume":"27","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2024092614550500000_2024.09.21.614277v1.23","first-page":"199","article-title":"Translational Concepts of mGluR5 in Synaptic Diseases of the Brain","volume":"3","year":"2012","journal-title":"Front Pharmacol"},{"key":"2024092614550500000_2024.09.21.614277v1.24","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-011-8187-z"},{"issue":"1","key":"2024092614550500000_2024.09.21.614277v1.25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-020-0582-0","article-title":"PET imaging of mGluR5 in Alzheimer\u2019s disease","volume":"12","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"2024092614550500000_2024.09.21.614277v1.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1996.tb01611.x"},{"issue":"1","key":"2024092614550500000_2024.09.21.614277v1.27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41467-022-35680-w","article-title":"mGluR5 is transiently confined in perisynaptic nanodomains to shape synaptic function","volume":"14","year":"2023","journal-title":"Nat Commun"},{"key":"2024092614550500000_2024.09.21.614277v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00697-X"},{"key":"2024092614550500000_2024.09.21.614277v1.29","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997"},{"key":"2024092614550500000_2024.09.21.614277v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22768-x"},{"issue":"1","key":"2024092614550500000_2024.09.21.614277v1.31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-020-05661-2","article-title":"E1ects of blocking mGluR5 on primate dorsolateral prefrontal cortical neuronal firing and working memory performance","volume":"238","year":"2021","journal-title":"Psychopharmacology (Berl"},{"key":"2024092614550500000_2024.09.21.614277v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.04.029"},{"key":"2024092614550500000_2024.09.21.614277v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.06.036"},{"key":"2024092614550500000_2024.09.21.614277v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv356"},{"key":"2024092614550500000_2024.09.21.614277v1.35","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1858-12.2012"},{"key":"2024092614550500000_2024.09.21.614277v1.36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi8593"},{"key":"2024092614550500000_2024.09.21.614277v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.06.023"},{"key":"2024092614550500000_2024.09.21.614277v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.077"},{"key":"2024092614550500000_2024.09.21.614277v1.39","doi-asserted-by":"crossref","first-page":"107785","DOI":"10.1016\/j.neuropharm.2019.107785","article-title":"A positive allosteric modulator of mGluR5 promotes neuroprotective e1ects in mouse models of Alzheimer\u2019s disease","volume":"160","year":"2019","journal-title":"Neuropharmacology"},{"key":"2024092614550500000_2024.09.21.614277v1.40","unstructured":"Mecca AP , Salardini E , Gallezot JD , O\u2019dell RS , Young J , Cooper E , et al. A phase 1a single ascending dose study of the safety, tolerability, and brain receptor occupancy of BMS984923 in healthy older adults. Clinical Trials on Alzheimer\u2019s Disease; October 27, 2023; Boston, MA-USA2023."},{"key":"2024092614550500000_2024.09.21.614277v1.41","unstructured":"Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923 [NCT04805983]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04805983?term=NCT04805983&rank=1. Accessed on September 20,2024."},{"key":"2024092614550500000_2024.09.21.614277v1.42","unstructured":"Food E1ect Study of BMS-984923 in Healthy Older Adult Volunteers [NCT05817643]. Available from: https:\/\/clinicaltrials.gov\/search?term=NCT05817643. Accessed on September 20,2024."},{"issue":"6","key":"2024092614550500000_2024.09.21.614277v1.43","doi-asserted-by":"crossref","first-page":"e01632","DOI":"10.1002\/brb3.1632","article-title":"Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer\u2019s dementia","volume":"10","year":"2020","journal-title":"Brain Behav"},{"issue":"1","key":"2024092614550500000_2024.09.21.614277v1.44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13195-024-01385-z","article-title":"Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer\u2019s disease: A [(18)F]PSS232 PET\/MRI study","volume":"16","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"2024092614550500000_2024.09.21.614277v1.45","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/alz.12582","article-title":"Synaptic density and cognitive performance in Alzheimer\u2019s disease: A PET imaging study with [(11) C]UCB-J","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"2024092614550500000_2024.09.21.614277v1.46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900345106"},{"key":"2024092614550500000_2024.09.21.614277v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.01.021"},{"key":"2024092614550500000_2024.09.21.614277v1.48","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/52\/5\/019"},{"key":"2024092614550500000_2024.09.21.614277v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.09.027"},{"key":"2024092614550500000_2024.09.21.614277v1.50","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17724947"},{"key":"2024092614550500000_2024.09.21.614277v1.51","doi-asserted-by":"publisher","DOI":"10.1118\/1.4819820"},{"key":"2024092614550500000_2024.09.21.614277v1.52","doi-asserted-by":"crossref","unstructured":"Carson R , Barker C , Liow J-S , Johnson C. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. IEEE Nuclear Science Symposium; Portland, OR, USA 2003. p. 3281\u20135.","DOI":"10.1109\/NSSMIC.2003.1352597"},{"key":"2024092614550500000_2024.09.21.614277v1.53","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/57\/21\/R119"},{"issue":"7","key":"2024092614550500000_2024.09.21.614277v1.54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12149-017-1185-0","article-title":"A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [(18)F]THK5351 and [(11)C]PIB","volume":"31","year":"2017","journal-title":"Ann Nucl Med"},{"key":"2024092614550500000_2024.09.21.614277v1.55","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200212000-00004"},{"issue":"4","key":"2024092614550500000_2024.09.21.614277v1.56","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00259-023-06487-8","article-title":"The regional pattern of age-related synaptic loss in the human brain di1ers from gray matter volume loss: in vivo PET measurement with [(11)C]UCB-J","volume":"51","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024092614550500000_2024.09.21.614277v1.57","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.228080"},{"key":"2024092614550500000_2024.09.21.614277v1.58","doi-asserted-by":"crossref","first-page":"117877","DOI":"10.1016\/j.neuroimage.2021.117877","article-title":"Synaptic density in healthy human aging is not influenced by age or sex: a (11)C-UCB-J PET study","volume":"232","year":"2021","journal-title":"Neuroimage"},{"key":"2024092614550500000_2024.09.21.614277v1.59","doi-asserted-by":"crossref","first-page":"118217","DOI":"10.1016\/j.neuroimage.2021.118217","article-title":"E1ect of age on brain metabotropic glutamate receptor subtype 5 measured with [(18)F]FPEB PET","volume":"238","year":"2021","journal-title":"Neuroimage"},{"issue":"6","key":"2024092614550500000_2024.09.21.614277v1.60","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1002\/alz.13817","article-title":"Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment","volume":"20","year":"2024","journal-title":"Alzheimers Dement"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.21.614277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:06:27Z","timestamp":1768460787000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.09.21.614277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":60,"URL":"https:\/\/doi.org\/10.1101\/2024.09.21.614277","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13195-025-01739-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,9,24]]},"subtype":"preprint"}}